Amgen Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al
| Amgen Inc. and Les Laboratoires Servier |
| Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. |
| 1:2020cv00075 |
| January 17, 2020 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 30, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 STIPULATION TO EXTEND TIME for Defendants to respond to Plaintiffs' Complaint (D.I. 1) to April 20, 2020 - filed by Amgen Inc., Les Laboratoires Servier. (Egan, Brian) |
SO ORDERED, re #9 STIPULATION TO EXTEND TIME for Defendants to respond to Plaintiffs' Complaint (D.I. 1) to April 20, 2020 filed by Amgen Inc., Les Laboratoires Servier, Set/Reset Answer Deadlines: Cadila Healthcare Ltd. answer due 4/20/2020; Zydus Pharmaceuticals (USA) Inc. answer due 4/20/2020. Signed by Judge Colm F. Connolly on 1/30/2020. (nmf)
|
| Filing 8 WAIVER OF SERVICE returned executed by Les Laboratoires Servier, Amgen Inc.: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 1/21/2020, answer due 3/23/2020. (Egan, Brian) |
| Filing 7 WAIVER OF SERVICE returned executed by Les Laboratoires Servier, Amgen Inc.: For Cadila Healthcare Ltd. waiver sent on 1/21/2020, answer due 3/23/2020. (Egan, Brian) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:20-cv-00065-CFC, 1:20-cv-00075-CFC (rjb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Servier SAS for Les Laboratoires Servier filed by Les Laboratoires Servier. (lak) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amgen Inc.. (lak) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,361,649 B2 ;7,361,650 B2 ;7,867,996 B2 ;7,879,842 B2. (lak) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/9/2019. Date of Expiration of Patent: See attachment.Thirty Month Stay Deadline: 6/9/2022. (lak) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2828520.) - filed by Les Laboratoires Servier, Amgen Inc. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet) (lak) |
| Summons Issued with Magistrate Consent Notice attached as to Cadila Healthcare Ltd. on 1/17/2020; Zydus Pharmaceuticals (USA) Inc. on 1/17/2020. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
